(2) Falutz J, Mamputu JC, Potvin D, Moyle G, et al
[PubMed] Kannengiesser K, Maaser C, Heidemann J, et al
Another large study, TROPION-Lung14, is looking at whether combining Dato-DXd with osimertinib works better than osimertinib alone in people with advanced EGFR-mutated NSCLC who havent had previous treatment
These results were confirmed in rabbits that were initially sensitized with PGN by subcutaneous injection, followed by oral administration of 1% PGN in drinking water for 12 or 28 months (Kitano et al
MT-2 protocols are long (often 4-8 weeks), so you will go through multiple reconstitution cycles
Regulatory oversight of clinical trials in the UK is managed by the MHRA in conjunction with the Health Research Authority (HRA)